These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36724820)

  • 1. PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis.
    Zhao Y; Ruan X; Cheng J; Xu X; Gu M; Mueck AO
    Climacteric; 2023 Apr; 26(2):135-142. PubMed ID: 36724820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors.
    Clark NC; Friel AM; Pru CA; Zhang L; Shioda T; Rueda BR; Peluso JJ; Pru JK
    Cancer Biol Ther; 2016; 17(3):262-71. PubMed ID: 26785864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells.
    You JH; Lee J; Roh JL
    J Exp Clin Cancer Res; 2021 Nov; 40(1):350. PubMed ID: 34749765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells.
    Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W
    Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WTAP Mediates NUPR1 Regulation of LCN2 Through m
    Tan M; He Y; Yi J; Chen J; Guo Q; Liao N; Peng L
    Biochem Genet; 2024 Apr; 62(2):876-891. PubMed ID: 37477758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.
    Yu M; Gai C; Li Z; Ding D; Zheng J; Zhang W; Lv S; Li W
    Cancer Sci; 2019 Oct; 110(10):3173-3182. PubMed ID: 31464035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.
    Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S
    Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of miR-181a regulates the Warburg effect in triple-negative breast cancer.
    Wang Y; Tahiri H; Yang C; Gu M; Ruan X; Hardy P
    Climacteric; 2023 Feb; 26(1):64-71. PubMed ID: 36459490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGRMC1 Inhibits Progesterone-Evoked Proliferation and Ca
    Cantonero C; Salido GM; Rosado JA; Redondo PC
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis.
    Zhao P; Song H; Gao F; Chen L; Qiu J; Jin J; Pan C; Tang Y; Chen M; Pan Y; Li Y; Huang L; Yang J; Hao X
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
    Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
    J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of the Implication of PGRMC1 in Triple-Negative Breast Cancer.
    Xu X; Ruan X; Zhang Y; Cai G; Ju R; Yang Y; Cheng J; Gu M
    Front Bioeng Biotechnol; 2021; 9():714030. PubMed ID: 34746100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGM5P3-AS1 regulates MAP1LC3C to promote cell ferroptosis and thus inhibiting the malignant progression of triple-negative breast cancer.
    Qi L; Sun B; Yang B; Lu S
    Breast Cancer Res Treat; 2022 Jun; 193(2):305-318. PubMed ID: 35325342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis.
    Song X; Wang X; Chen X; Yu Z; Zhou Y
    J Proteomics; 2024 Feb; 292():105055. PubMed ID: 38040194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTGER3 knockdown inhibits the vulnerability of triple-negative breast cancer to ferroptosis.
    Wang S; Zhang Y; Zhang D; Meng J; Che N; Zhao X; Liu T
    Cancer Sci; 2024 Jun; 115(6):2067-2081. PubMed ID: 38566528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-inducer of ferroptosis for targeted chemotherapy of human triple negative breast carcinoma.
    Shetake NG; Das SK; Kumar A; Pandey BN
    Biomater Adv; 2024 Jul; 161():213868. PubMed ID: 38677038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
    Li M; Li A; Zhou S; Lv H; Yang W
    J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-4 inhibits triple negative breast cancer by inducing cell apoptosis and promoting LCN2-dependent ferroptosis.
    Sun G; Wang J; Liu F; Zhao C; Cui S; Wang Z; Liu Z; Zhang Q; Xiang C; Zhang Y; Galons H; Yu P; Teng Y
    Biochem Pharmacol; 2024 Apr; 222():116077. PubMed ID: 38395264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.